Stifel Financial
TGTX icon

Stifel Financial’s TG Therapeutics TGTX Stock Holding History

Stifel Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
49,665
+4,523
+10% +$185K ﹤0.01% 1846
2026
Q1 		$1.5M Buy
45,142
+7,673
+20% +$229K ﹤0.01% 2157
2025
Q4 		$1.12M Buy
37,469
+25,349
+209% +$828K ﹤0.01% 2359
2025
Q3 		$438K Sell
12,120
-5,395
-31% -$178K ﹤0.01% 2894
2025
Q2 		$630K Buy
+17,515
New +$652K ﹤0.01% 2626
2019
Q2 		– Sell
-14,420
Closed -$116K – 3044
2019
Q1 		$116K Hold
14,420
– – ﹤0.01% 2684
2018
Q4 		$59K Buy
+14,420
New +$71.7K ﹤0.01% 2601

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Stifel Financial's TGTX Position: Q2 2026 in Review

Stifel Financial increased its TG Therapeutics (TGTX) stake by 10% in Q2 2026, buying an estimated $185K and bringing the position to 49,665 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Stifel Financial first reported a position in TGTX in Q4 2018 and has held it in 7 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Stifel Financial held 49,665 shares of TG Therapeutics worth $2.73M as of Q2 2026.
  • Stifel Financial bought 4,523 TG Therapeutics shares in Q2 2026, an estimated $185K.
  • TG Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1846 holding.
  • Stifel Financial first reported a position in TG Therapeutics in Q4 2018 and has held it in 7 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.